BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 18480004)

  • 1. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
    Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
    Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
    Nonaka D; Chiriboga L; Rubin BP
    J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
    Dundr P; Povýsil C; Tvrdík D
    Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox10: a pan-schwannian and melanocytic marker.
    Nonaka D; Chiriboga L; Rubin BP
    Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
    Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
    Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
    Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
    Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversial nosology of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas.
    Nascimento AF; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1363-70. PubMed ID: 17721192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
    Hirose T; Tani T; Shimada T; Ishizawa K; Shimada S; Sano T
    Mod Pathol; 2003 Apr; 16(4):293-8. PubMed ID: 12692193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of CD10 in peripheral nerve sheath tumors.
    Cabibi D; Zerilli M; Caradonna G; Schillaci L; Belmonte B; Rodolico V
    Anticancer Res; 2009 Aug; 29(8):3149-55. PubMed ID: 19661328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
    Sundram U; Harvell JD; Rouse RV; Natkunam Y
    Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas.
    Kaddu S; Leinweber B
    Am J Dermatopathol; 2009 Apr; 31(2):137-9. PubMed ID: 19318798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine use of immunohisto-chemistry may increase the frequency of hybrid peripheral nerve sheath tumors.
    Pusiol T; Zorzi MG; Morichetti D; Piscioli F
    Am J Dermatopathol; 2011 Aug; 33(6):634-6. PubMed ID: 21712692
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
    Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
    Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors.
    Weiss SW; Langloss JM; Enzinger FM
    Lab Invest; 1983 Sep; 49(3):299-308. PubMed ID: 6310227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative ultrastructural and immunohistochemical study of perineurioma and neurofibroma of the oral mucosa.
    Ide F; Shimoyama T; Horie N; Kusama K
    Oral Oncol; 2004 Oct; 40(9):948-53. PubMed ID: 15380174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.